Table 2.
Laboratory parameters* in COVID-19 patients enrolled in the study (N = 32).
| Parameter (units) | Baseline (acute COVID-19) Mean (SD, range) |
Follow-up (post COVID-19) Mean (SD, range) |
p** |
|---|---|---|---|
| HTC (%) | 39.34 (5.52, 28 – 48) | 42.4 (4.1, 33 – 49) | 0.0003 |
| WBC (× 106/L) | 6372.8 (2232.9, 1910–13,340) | 7498.7 (1800.1, 4350–10,780) | 0.006 |
| Neutrophils (× 106/L) | 3723.1 (1798.7, 650–8730) | 4331. 8 (1521.2, 1690–7130) | 0.1 |
| Lymphocytes (× 106/L) | 1874.7 (659.9, 770–3450) | 2454.4 (713.8, 1340–4490) | < 0.0001 |
| Platelets (× 109/L) | 312.3 (135.9, 113–673) | 248 (54.4, 111–336) | 0.01 |
| PT (ratio) | 1.2 (0.13, 0.97–1.61) | 1.06 (0.1, 0.91–1.44) | < 0.0001 |
| PTT (ratio) | 1.16 (0.14, 0.9–1.47) | 0.94 (0.1, 0.71–1.19) | < 0.0001 |
| Fibrinogen (mg/dL) | 536.5 (119.0, 320–701) | 425.6 (108, 193–701) | 0.003 |
| D-Dimer (μg/L) | 673.6 (501.5, 200–2279) | 365.6 (177.8, 199–803) | 0.003 |
| CRP (mg/L) | 21.8 (33.3, 1–142) | 2.3 (1.5, 0.3–5) | 0.002 |
| Creatinine (mg/dL) | 0.82 (0.18, 0.44–1.2) | 0.84 (0.2, 0.39–1.26) | 0.15 |
COVID-19 Coronavirus disease 2019, SD standard deviation, HTC hematocrit, WBC white blood cells, PT prothrombin time, PTT partial thromboplastin time, CRP C-reactive protein, LDH lactic acid dehydrogenase, CK creatine kinase.
*The closest available within 3 days prior to the fundus examination at baseline and the same day of fundus photos at follow-up.
**T test (paired).